Trials / Recruiting
RecruitingNCT05868408
Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants
Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants: a Double-blind, Randomized, Controlled, Multi-arm Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 234 (estimated)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 0 Days – 28 Days
- Healthy volunteers
- Accepted
Summary
This study will assess the effect of partially hydrolyzed, whey-based infant formulas on growth and gastrointestinal tolerance in healthy term infants.
Conditions
- Infant Nutritional Physiological Phenomena
- Infant Formula
- Infant Health
- Infant Development
- Growth and Development
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Control Formula | Infant formula made with intact protein - minimum 1.8g protein/100kcal |
| OTHER | Experimental Formula 1 | Infant formula made with hydrolyzed protein - minimum 1.9g protein/100kcal |
| OTHER | Experimental Formula 2 | Infant formula made with hydrolyzed protein - minimum 1.9g protein/100kcal |
Timeline
- Start date
- 2023-08-17
- Primary completion
- 2027-12-01
- Completion
- 2028-06-01
- First posted
- 2023-05-22
- Last updated
- 2025-12-19
Locations
3 sites across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT05868408. Inclusion in this directory is not an endorsement.